Tests a breathing technique to ease anxiety before surgery for peritoneal cancer
Tests a cardiac coherence breathing technique to reduce anxiety in adults before peritoneal cancer surgery.
Plain-language title generated from the registry record
Registry title: Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Key facts
- Where
- Montpellier, FranceSee the site
Where in France
- ICMMontpellier, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut du Cancer de Montpellier - Val d'Aurelle
- Trial code
- NCT04024917
- Record updated
- 16 January 2026
- Original description
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.Read full original descriptionShow less
Implementation of a Cardiac Coherence Program to Reduce Anxiety in Patients With Peritoneal Carcinosis Treated by Surgery: Randomized Pilot Study
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.
Inclusion: Age over 18 years; Patients with peritoneal carcinosis awaiting cytoreductive surgery; Patients who scored strictly above 3 on the visual analogue anxiety scale and/or the psychological distress scale; Patients with sufficient command of the French language; Patient affiliated to a French social security system; Patient hospitalized at the Institute of cancer of Montpellier the day before his cytoreductive surgery (at T1 = D-1); Signing of informed consent before any specific trial procedure.
Exclusion: Presence of proven psychiatric disorders (e.g., mental retardation, psychotic disorders, learning disabilities, attention deficit/hyperactivity, bipolar disorder, etc.) other than mood disorders that are reactive to the disease experience, or receiving psychotic treatment that may impair thinking, judgment or discernment; Patient with a history of uncontrolled neurological pathology within the last 6 months before inclusion in the trial; Patients with a history of psychoactive substance dependence (excluding smoking) in the last 6 months before inclusion in the trial; Patients who already have daily practice of cardiac coherence; Patients who have had a heart transplant or bypass surgery in the Year before surgery; Ongoing cardiac arrhythmias; Patient with chronic obstructive pulmonary disease; Known severe heart failure with ventricular ejection fraction strictly Below 40 %; Physical or sensory inability to respond to questionnaires; Patients with brain metastases; Known natural bradycardia 50 beats per minute; Beta-blocker intake in progress; Chronic uncontrolled pain and making it difficult to practice the technique; Legal incapacity (patient under guardianship or curatorship).